 Phytopharm plc is developing CoganeTM which is a new medicine for the treatment of Parkinsons disease PD. The purpose of the study is to find out if Cogane is safe and well tolerated in both healthy volunteers and Parkinsons disease patients and to determine if there is a difference in the way that the body deals with Cogane pharmacokinetics between these two groups. 